The scientist’s investigation covers issues in Pharmacology, Dopamine, Microdialysis, Vigabatrin and Addiction. His work carried out in the field of Pharmacology brings together such families of science as Clinical trial and GABAergic. Stephen L. Dewey interconnects Nucleus accumbens and Striatum in the investigation of issues within Microdialysis.
The Nucleus accumbens study combines topics in areas such as Neurochemical and Nicotine. His work is dedicated to discovering how Vigabatrin, Methamphetamine are connected with Reuptake and other disciplines. His Conditioned place preference research is multidisciplinary, incorporating elements of Agonist and Dopaminergic.
His primary areas of investigation include Pharmacology, Dopamine, Vigabatrin, Internal medicine and Endocrinology. His studies deal with areas such as Neurotransmitter, Nucleus accumbens, Gamma-Vinyl-GABA, Addiction and Nicotine as well as Pharmacology. Stephen L. Dewey has researched Nucleus accumbens in several fields, including Sprague dawley, Microdialysis and Detoxification.
His research in Addiction intersects with topics in Pain management, GABAergic and γ vinyl gaba. Much of his study explores Dopamine relationship to Neurochemical. His Vigabatrin study combines topics in areas such as Morphine, Anesthesia, Saline, Methamphetamine and Drug.
His primary scientific interests are in Globus pallidus, Internal medicine, Endocrinology, Pharmacology and Methadone. His Globus pallidus research integrates issues from Cerebellum, Knockout mouse and Brainstem. In the subject of general Internal medicine, his work in Hypoxia, Superoxide dismutase and Nitric oxide is often linked to Superoxide, thereby combining diverse domains of study.
His research integrates issues of Striatum, Dopamine, Young adult, Regimen and Gamma-Vinyl-GABA in his study of Pharmacology. Stephen L. Dewey is interested in Nucleus accumbens, which is a branch of Dopamine. His work in Methadone covers topics such as Ventral striatum which are related to areas like Opioid.
Stephen L. Dewey focuses on Immunology, Oxidative stress, Brain damage, Hippocampal formation and Pharmacology. His Immunology research includes themes of Receptor, Fear conditioning, Blood–brain barrier and Neuron. His Brain damage research includes elements of Nitric oxide, Cell damage and Pathology.
Hippocampal formation is a subfield of Endocrinology that he explores. His Pharmacology research incorporates themes from Nucleus accumbens, Dopamine, Anticonvulsant, Vigabatrin and Aminobutyric acid. The study incorporates disciplines such as Striatum and Nicotine in addition to Aminobutyric acid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comparison between Intraperitoneal and Oral Methylphenidate Administration: A Microdialysis and Locomotor Activity Study
Madina R. Gerasimov;Maja Franceschi;Nora D. Volkow;Andrew Gifford.
Journal of Pharmacology and Experimental Therapeutics (2000)
A novel strategy for the treatment of cocaine addiction
Stephen L. Dewey;Stephen L. Dewey;Alexander E. Morgan;Charles R. Ashby;Bryan Horan.
Effects of acute alcohol intoxication on cerebral blood flow measured with PET.
Nora D. Volkow;Nizar Mullani;Lance Gould;Stephen S. Adler.
Psychiatry Research-neuroimaging (1988)
PET and drug research and development.
Joanna S. Fowler;Nora D. Volkow;Gene-Jack Wang;Yu-Shin Ding.
The Journal of Nuclear Medicine (1999)
Safety and efficacy of γ-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction†
Jonathan D. Brodie;Emilia Figueroa;Eugene M. Laska;Eugene M. Laska;Stephen L. Dewey;Stephen L. Dewey.
The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats.
Stephanie A. Kushner;Stephen L. Dewey;Conan Kornetsky.
Journal of Pharmacology and Experimental Therapeutics (1999)
Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor.
Madina R. Gerasimov;Maja Franceschi;Nora D. Volkow;Onarae Rice.
Treating cocaine addiction: From preclinical to clinical trial experience with γ‐vinyl GABA
Jonathan D. Brodie;Emilia Figueroa;Stephen L. Dewey;Stephen L. Dewey.
Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine.
Wynne K Schiffer;Wynne K Schiffer;N. D. Volkow;J. S. Fowler;D. L. Alexoff.
Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine
Madina R. Gerasimov;Charles R. Ashby;Eliot L. Gardner;Mark J. Mills.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: